Open AccessPB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT‐VERSUS‐HOST DISEASE
Author(s) -
Koreth J.,
Kean L.,
Chinn L.,
Acevedo L. M.,
Bandman O.,
Rothman J.,
Connelly S.,
Thomas D.,
Cutler C.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851612.99253.8a
Subject(s) - medicine , placebo , alcam , randomized controlled trial , graft versus host disease , gastroenterology , immunology , disease , cell adhesion molecule , pathology , alternative medicine